A division bench of the Bombay High Court has, in a landmark
move, held that seven bulk drugs —- ciprofloxacin, norfloxacin,
salbutamol, theophylline, cloxacillin, doxycycline and glipizide
— do not fall under the purview of price control and that the
current Drug Price Control Order is not applicable to these
drugs. Currently, roughly 74 drugs are covered under the DPCO.
